Guidant launches beating heart surgery device:
This article was originally published in Clinica
Executive Summary
Guidant has introduced its next-generation AXIUS vacuum 2 stabiliser system, which allows surgeons to perform coronary artery bypass surgery without stopping the heart and placing patients on a heart-lung machine. The device stabilises the area around the blocked vessel and allows doctors to graft the vessel without compromising the heart's natural pumping action. Beating heart surgery, which accounts for nearly 25% of US bypass procedures, has been shown to allow faster patient recovery and is associated with fewer side-effects, such as memory loss, said the firm.
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.